|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Conteduca V, Sansonno D, Russi S and
Dammacco F: Precancerous colorectal lesions (Review). Int J Oncol.
43:973–984. 2013.PubMed/NCBI
|
|
3
|
Haus EL and Smolensky MH: Shift work and
cancer risk: potential mechanistic roles of circadian disruption,
light at night, and sleep deprivation. Sleep Med Rev. 17:273–284.
2013. View Article : Google Scholar
|
|
4
|
Lahti T, Merikanto I and Partonen T:
Circadian clock disruptions and the risk of cancer. Ann Med.
44:847–853. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Landgraf D, Shostak A and Oster H: Clock
genes and sleep. Pflugers Archiv. 463:3–14. 2012. View Article : Google Scholar
|
|
6
|
Masri S, Zocchi L, Katada S, Mora E and
Sassone-Corsi P: The circadian clock transcriptional complex:
metabolic feedback intersects with epigenetic control. Ann NY Acad
Sci. 1264:103–109. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Panda S, Antoch MP, Miller BH, et al:
Coordinated transcription of key pathways in the mouse by the
circadian clock. Cell. 109:307–320. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schibler U: The daily timing of gene
expression and physiology in mammals. Dialogues Clin Neurosci.
9:257–272. 2007.PubMed/NCBI
|
|
9
|
Ripperger JA and Merrow M: Perfect timing:
epigenetic regulation of the circadian clock. FEBS Lett.
585:1406–1411. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Storch KF, Lipan O, Leykin I, et al:
Extensive and divergent circadian gene expression in liver and
heart. Nature. 417:78–83. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wood P, Yang X and Hrushesky W: The role
of circadian rhythm in pathogenesis of colorectal cancer. Curr
Colorectal Cancer Rep. 6:74–81. 2010. View Article : Google Scholar
|
|
12
|
Kang TH and Sancar A: Circadian regulation
of DNA excision repair: implications for chrono-chemotherapy. Cell
Cycle. 8:1665–1667. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu EA and Weaver DR: Disrupting the
circadian clock: gene-specific effects on aging, cancer, and other
phenotypes. Aging. 3:479–493. 2011.PubMed/NCBI
|
|
14
|
Yang MY, Yang WC, Lin PM, et al: Altered
expression of circadian clock genes in human chronic myeloid
leukemia. J Biol Rhythms. 26:136–148. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen-Goodspeed M and Lee CC: Tumor
suppression and circadian function. J Biol Rhythms. 22:291–298.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dijk DJ and Archer SN: PERIOD3, circadian
phenotypes, and sleep homeostasis. Sleep Med Rev. 14:151–160. 2010.
View Article : Google Scholar
|
|
17
|
Ebisawa T: Analysis of the molecular
pathophysiology of sleep disorders relevant to a disturbed
biological clock. Mol Genet Genomics. 288:185–193. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thompson CL, Larkin EK, Patel S, Berger
NA, Redline S and Li L: Short duration of sleep increases risk of
colorectal adenoma. Cancer. 117:841–847. 2011. View Article : Google Scholar :
|
|
19
|
Burch JB, Wirth M and Yang X: Disruption
of circadian rhythms and sleep: role in carcinogenesis. The
Encyclopedia of Sleep. Kushida CA: 3. Academic Press; Waltham, MA:
pp. 150–155. 2013, View Article : Google Scholar
|
|
20
|
Jiao L, Duan Z, Sangi-Haghpeykar H, Hale
L, White DL and El-Serag HB: Sleep duration and incidence of
colorectal cancer in postmenopausal women. Br J Cancer.
108:213–221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wirth MD, Burch JB, Hébert JR, et al:
Case-control study of breast cancer in India: Role of PERIOD3 clock
gene length polymorphism and chronotype. Cancer Invest. 32:321–329.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schernhammer ES, Laden F, Speizer FE, et
al: Night-shift work and risk of colorectal cancer in the nurses’
health study. J Natl Cancer Inst. 95:825–828. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Parent MÉ, El-Zein M, Rousseau MC, Pintos
J and Siemiatycki J: Night work and the risk of cancer among men.
Am J Epidemiol. 176:751–759. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
IARC Monographs on the Evaluation of
Carcinogenic Risks to Humans. Painting, Firefighting and Shiftwork.
International Agency for Research on Cancer. World Health
Organization; 98. Lyon, France: 2010
|
|
25
|
Scheiermann C, Kunisaki Y and Frenette PS:
Circadian control of the immune system. Nat Rev Immunol.
13:190–198. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Arjona A, Silver AC, Walker WE and Fikrig
E: Immunity’s fourth dimension: approaching the circadian-immune
connection. Trends Immunol. 33:607–612. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Climent J, Perez-Losada J, Quigley DA, et
al: Deletion of the PER3 gene on chromosome 1p36 in recurrent
ER-positive breast cancer. J Clin Oncol. 28:3770–3778. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Neumann O, Kesselmeier M, Geffers R, et
al: Methylome analysis and integrative profiling of human HCCs
identify novel protumorigenic factors. Hepatology. 56:1817–1827.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cao Q, Gery S, Dashti A, et al: A role for
the clock gene Per1 in prostate cancer. Cancer Res. 69:7619–7625.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gery S, Komatsu N, Baldjyan L, Yu A, Koo D
and Koeffler HP: The circadian gene Per1 plays an important role in
cell growth and DNA damage control in human cancer cells. Mol Cell.
22:375–382. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hua H, Wang Y, Wan C, et al: Circadian
gene mPer2 overexpression induces cancer cell apoptosis. Cancer
Sci. 97:589–596. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang X, Yan D, Teng M, et al: Reduced
expression of PER3 is associated with incidence and development of
colon cancer. Ann Surg Oncol. 19:3081–3088. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhu Y, Brown HN, Zhang Y, Stevens RG and
Zheng T: Period3 structural variation: a circadian biomarker
associated with breast cancer in young women. Cancer Epidemiol
Biomarkers Prev. 14:268–270. 2005.PubMed/NCBI
|
|
34
|
Mazzoccoli G, Panza A, Valvano MR, et al:
Clock gene expression levels and relationship with clinical and
pathological features in colorectal cancer patients. Chronobiol
Int. 28:841–851. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Oshima T, Takenoshita S, Akaike M, et al:
Expression of circadian genes correlates with liver metastasis and
outcomes in colorectal cancer. Oncol Rep. 25:1439–1446. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mostafaie N, Kállay E, Sauerzapf E, et al:
Correlated downregulation of estrogen receptor beta and the
circadian clock gene Per1 in human colorectal cancer. Mol Carcinog.
48:642–647. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wirth M, Burch J, Violanti J, et al:
Association of the Period3 clock gene length polymorphism with
salivary cortisol secretion among police officers. Neuro Endocrinol
Lett. 34:27–37. 2013.PubMed/NCBI
|
|
38
|
Lázár AS, Slak A, Lo JC, et al: Sleep,
diurnal preference, health, and psychological well-being: a
prospective single-allelic-variation study. Chronobiol Int.
29:131–146. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pereira DS, Tufik S, Louzada FM, et al:
Association of the length polymorphism in the human Per3 gene with
the delayed sleep-phase syndrome: does latitude have an influence
upon it? Sleep. 28:29–32. 2005.PubMed/NCBI
|
|
40
|
Viola AU, Chellappa SL, Archer SN, et al:
Interindividual differences in circadian rhythmicity and sleep
homeostasis in older people: effect of a PER3 polymorphism.
Neurobiol Aging. 33:1010.e17–1010.e27. 2012. View Article : Google Scholar
|
|
41
|
Chellappa SL, Viola AU, Schmidt C, et al:
Human melatonin and alerting response to blue-enriched light depend
on a polymorphism in the clock gene PER3. J Clin Endocrinol Metab.
97:E433–E437. 2012. View Article : Google Scholar
|
|
42
|
Guess J, Burch JB, Ogoussan K, et al:
Circadian disruption, Per3, and human cytokine secretion. Integr
Cancer Ther. 8:329–336. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Benedetti F, Dallaspezia S, Colombo C,
Pirovano A, Marino E and Smeraldi E: A length polymorphism in the
circadian clock gene Per3 influences age at onset of bipolar
disorder. Neurosci Lett. 445:184–187. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Dai H, Zhang L, Cao M, et al: The role of
polymorphisms in circadian pathway genes in breast tumorigenesis.
Breast Cancer Res Treat. 127:531–540. 2011. View Article : Google Scholar
|
|
45
|
Karantanos T, Theodoropoulos G, Gazouli M,
et al: Association of the clock genes polymorphisms with colorectal
cancer susceptibility. J Surg Oncol. 108:563–567. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ebisawa T, Uchiyama M, Kajimura N, et al:
Association of structural polymorphisms in the human period3 gene
with delayed sleep phase syndrome. EMBO Rep. 2:342–346. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nievergelt CM, Kripke DF, Barrett TB, et
al: Suggestive evidence for association of the circadian genes
PERIOD3 and ARNTL with bipolar disorder. Am J Med Genet B
Neuropsychiatr Genet. 141B:234–241. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Archer SN, Robilliard DL, Skene DJ, et al:
A length polymorphism in the circadian clock gene Per3 is linked to
delayed sleep phase syndrome and extreme diurnal preference. Sleep.
26:413–415. 2003.PubMed/NCBI
|
|
49
|
Rhodes DR, Kalyana-Sundaram S, Mahavisno
V, et al: Oncomine 3.0: genes, pathways, and networks in a
collection of 18,000 cancer gene expression profiles. Neoplasia.
9:166–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Barbosa AA, Pedrazzolli M, Koike BD and
Tufik S: Do Caucasian and Asian Clocks Tick Differently? Braz J Med
Biol Res. 43:96–99. 2010. View Article : Google Scholar
|
|
51
|
Gaspar C, Cardoso J, Franken P, et al:
Cross-species comparison of human and mouse intestinal polyps
reveals conserved mechanisms in adenomatous polyposis coli
(APC)-driven tumorigenesis. Am J Pathol. 172:1363–1380. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Sabates-Bellver J, Van der Flier LG, de
Palo M, et al: Transcriptome profile of human colorectal adenomas.
Mol Cancer Res. 5:1263–1275. 2007. View Article : Google Scholar
|
|
53
|
Skrzypczak M, Goryca K, Rubel T, et al:
Modeling oncogenic signaling in colon tumors by multidirectional
analyses of microarray data directed for maximization of analytical
reliability. PLoS One. 5:pii: e13091. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Xirasagar S, Hurley TG, Sros L and Hebert
JR: Quality and safety of screening colonoscopies performed by
primary care physicians with standby specialist support. Med Care.
48:703–709. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Rex DK, Kahi CJ, Levin B, et al:
Guidelines for colonoscopy surveillance after cancer resection: a
consensus update by the American Cancer Society and US
Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin.
56:160–167; quiz 185-166. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Krugluger W, Brandstaetter A, Kállay E, et
al: Regulation of genes of the circadian clock in human colon
cancer: reduced period-1 and dihydropyrimidine dehydrogenase
transcription correlates in high-grade tumors. Cancer Res.
67:7917–7922. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Karantanos T, Theodoropoulos G, Gazouli M,
Vaiopoulou A, Karantanou C, Lymberi M and Pektasides D: Expression
of clock genes in patients with colorectal cancer. Int J Biol
Markers. 28:280–285. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Tenesa A and Dunlop MG: New insights into
the aetiology of colorectal cancer from genome-wide association
studies. Nat Rev Genet. 10:353–358. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Tomlinson IP, Dunlop M, Campbell H, et al:
COGENT (COlorectal cancer GENeTics): an international consortium to
study the role of polymorphic variation on the risk of colorectal
cancer. Br J Cancer. 102:447–454. 2010. View Article : Google Scholar :
|
|
60
|
Mazzoccoli G, Palmieri O, Corritore G, et
al: Association study of a polymorphism in clock gene PERIOD3 and
risk of inflammatory bowel disease. Chronobiol Int. 29:994–1003.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Lee CC: The circadian clock and tumor
suppression by mammalian period genes. Methods Enzymol.
393:852–861. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Gery S and Koeffler HP: Circadian rhythms
and cancer. Cell Cycle. 9:1097–1103. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Voinescu BI and Coogan AN: A
variable-number tandem repeat polymorphism in PER3 is not
associated with chronotype in a population with self-reported sleep
problems. Sleep and Biological Rhythms. 10:23–26. 2012. View Article : Google Scholar
|
|
64
|
Osland TM, Bjorvatn BR, Steen VM and
Pallesen S: Association study of a variable-number tandem repeat
polymorphism in the clock gene PERIOD3 and chronotype in Norwegian
university students. Chronobiol Int. 28:764–770. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Barclay NL, Eley TC, Mill J, et al: Sleep
quality and diurnal preference in a sample of young adults:
associations with 5HTTLPR, PER3, and CLOCK 3111. Am J Med Genet B
Neuropsychiatr Genet. 156B:681–690. 2011. View Article : Google Scholar : PubMed/NCBI
|
